- Filed
- Feb 25, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 13.79M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 14.16M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $3.37M |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $554K |
| Dividends Paid | Q1 2025 · Mar 31, 2025 | $1.59M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $1.53M |
| Capex | Q1 2025 · Mar 31, 2025 | $516K |
| Capex | Q1 2025 · Mar 31, 2024 | $942K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | $6.62M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $19.7M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $48.3M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $45.64M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $26.28M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $163.18M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $165.9M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $145.41M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $147.27M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $158.84M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $154.12M |
| Current Liabilities | Q1 2025 · Mar 31, 2024 | $126.19M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $254.84M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $249.16M |
| Total Liabilities | Q1 2025 · Mar 31, 2024 | $223.54M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $313.45M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $303.72M |
| Current Assets | Q1 2025 · Mar 31, 2024 | $262.29M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $418.02M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $415.07M |
| Total Assets | Q1 2025 · Mar 31, 2024 | $368.95M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.13 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.08 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | $0.13 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.08 |
| Sga Expense restated | Q1 2025 · Mar 31, 2025 | $30.38M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $30.95M |
| Net Income | Q1 2025 · Mar 31, 2025 | $1.81M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.16M |
| Operating Income | Q1 2025 · Mar 31, 2025 | $2.31M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$943K |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $32.77M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $30.05M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $100.6M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $98.22M |